Inmune Bio Stock Technical Analysis
| INMB Stock | USD 1.56 0.05 3.11% |
As of the 29th of January, INmune Bio retains the Standard Deviation of 4.69, market risk adjusted performance of (0.1), and Risk Adjusted Performance of (0.02). INmune Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
INmune Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as INmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to INmuneINmune Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. Market participants price INmune higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive INmune Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
INmune Bio's market price often diverges from its book value, the accounting figure shown on INmune's balance sheet. Smart investors calculate INmune Bio's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since INmune Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
INmune Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to INmune Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of INmune Bio.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in INmune Bio on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding INmune Bio or generate 0.0% return on investment in INmune Bio over 90 days. INmune Bio is related to or competes with CEL SCI, Barinthus Biotherapeutics, Aligos Therapeutics, Tempest Therapeutics, OnKure Therapeutics, Skye Bioscience, and X4 Pharmaceuticals. INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patients innate i... More
INmune Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure INmune Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess INmune Bio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 22.66 | |||
| Value At Risk | (7.91) | |||
| Potential Upside | 6.82 |
INmune Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for INmune Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as INmune Bio's standard deviation. In reality, there are many statistical measures that can use INmune Bio historical prices to predict the future INmune Bio's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.11) |
INmune Bio January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.71 | |||
| Coefficient Of Variation | (3,072) | |||
| Standard Deviation | 4.69 | |||
| Variance | 22.02 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 22.66 | |||
| Value At Risk | (7.91) | |||
| Potential Upside | 6.82 | |||
| Skewness | 0.0534 | |||
| Kurtosis | 0.0234 |
INmune Bio Backtested Returns
INmune Bio holds Efficiency (Sharpe) Ratio of -0.0326, which attests that the entity had a -0.0326 % return per unit of risk over the last 3 months. INmune Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out INmune Bio's Risk Adjusted Performance of (0.02), market risk adjusted performance of (0.1), and Standard Deviation of 4.69 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.51, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, INmune Bio will likely underperform. At this point, INmune Bio has a negative expected return of -0.15%. Please make sure to check out INmune Bio's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if INmune Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.30 |
Below average predictability
INmune Bio has below average predictability. Overlapping area represents the amount of predictability between INmune Bio time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of INmune Bio price movement. The serial correlation of 0.3 indicates that nearly 30.0% of current INmune Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.3 | |
| Spearman Rank Test | -0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
INmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
INmune Bio Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of INmune Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About INmune Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of INmune Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of INmune Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on INmune Bio price pattern first instead of the macroeconomic environment surrounding INmune Bio. By analyzing INmune Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of INmune Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to INmune Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
INmune Bio January 29, 2026 Technical Indicators
Most technical analysis of INmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for INmune from various momentum indicators to cycle indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 3.71 | |||
| Coefficient Of Variation | (3,072) | |||
| Standard Deviation | 4.69 | |||
| Variance | 22.02 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.49) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 22.66 | |||
| Value At Risk | (7.91) | |||
| Potential Upside | 6.82 | |||
| Skewness | 0.0534 | |||
| Kurtosis | 0.0234 |
INmune Bio January 29, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as INmune stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 3,068 | ||
| Daily Balance Of Power | (1.25) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 1.58 | ||
| Day Typical Price | 1.57 | ||
| Price Action Indicator | (0.05) |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |